| | ||||||||
| C.R. Bard | ||||||||
| Finanzen | ||||||||
| 183,67 $ +1,68 (+0,92 %)
| ||||||||
| Nachrichten | ||||||||
Citigroup Initiates Coverage on CR Bard (BCR) to Buy with Price Target $220.00 Citigroup Initiates Coverage on CR Bard(NYSE:BCR). In a research note issued to the investors, the brokerage major Announces a price-target of ... Equity Research Analysts at Citigroup Initiated Coverage of CR Bard Inc (NYSE:BCR) with a "Buy ... - OctaFinance.com
| ||||||||
| Hologic Tops Large-Cap Stocks in Year-to-Date Performance The graph above reflects the performance of Hologic in comparison with Boston Scientific, Medtronic, C.R. Bard and the SPDR S&P 500 ETF (SPY) on ...
| ||||||||
| Sie erhalten diese E-Mail, weil Sie Google Alerts abonniert haben. |
Diesen Alert als RSS-Feed erhalten |
| Feedback geben |